Frazier Life Sciences Management »

Abivax SA F shares owned by Frazier Life Sciences Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Frazier Life Sciences Management from 13F filings

Historical chart of Frazier Life Sciences Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Frazier Life Sciences Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $32M 378k 84.90

More positions owned by Frazier Life Sciences Management

Mirum Pharmaceuticals (MIRM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Verona Pharma Sponsored Ads (VRNA)
Bridgebio Pharma (BBIO)
Arcutis Biotherapeutics (ARQT)
Phathom Pharmaceuticals (PHAT)
Krystal Biotech (KRYS)
Maze Therapeatics (MAZE)
Mbx Biosciences (MBX)
Disc Medicine (IRON)
Trevi Therapeutics (TRVI)
Tarsus Pharmaceuticals (TARS)
Kalvista Pharmaceuticals (KALV)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)

View all positions for Frazier Life Sciences Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F